🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: CT Screening

Found 0 matching trials

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

PHASE2

This phase II trial tests how well zanzalintinib (XL092) works in treating ...

Status

Recruiting

Location

Northwestern University

Start Date

2024-09-19

Trial ID

NCT06571734

Treatments Being Tested

Biospecimen Collection Computed Tomography Echocardiography Multigated Acquisition Scan Zanzalintinib

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

PHASE2

This phase II trial compares the effect of usual treatment of docetaxel che...

Status

Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2023-03-03

Trial ID

NCT05408845

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Computed Tomography Docetaxel Echocardiography Test Magnetic Resonance Imaging Multigated Acquisition Scan Questionnaire Administration Trastuzumab Trastuzumab Deruxtecan Trastuzumab Emtansine

Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT

The goal of this clinical trial is to evaluate whether an AI tool that aler...

Status

Recruiting

Location

Massachusetts General Hospital

Start Date

2025-05-20

Trial ID

NCT06910956

Treatments Being Tested

CXR-LC

A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology

N/A

This is a prospective, multi-center study to evaluate the diagnostic perfor...

Status

Completed

Location

Florida Lung Asthma and Sleep Specialists P.A.

Start Date

2015-08-13

Trial ID

NCT02512757

Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma

PHASE1

This phase I/II trial tests the safety, side effects, and best dose of PLX2...

Status

Withdrawn

Location

Multiple Locations

Start Date

2023-01-13

Trial ID

NCT05677373

Treatments Being Tested

BRD4 Inhibitor PLX2853 Trametinib Computed Tomography Magnetic Resonance Imaging Biospecimen collection Biospecimen collection

Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PHASE2

This phase II trial studies how well the addition of nemtabrutinib to lisoc...

Status

Recruiting

Location

Fred Hutch/University of Washington Cancer Consortium

Start Date

2026-09-01

Trial ID

NCT07194980

Treatments Being Tested

Nemtabrutinib Lisocabtagene Maraleucel

Early Stage Lung Cancer Screening With Low-dose Computed Tomographic

The present study is a randomized controlled trial of LDCT screening for lu...

Status

Unknown

Location

Shanghai Chest hospital

Start Date

2014-01

Trial ID

NCT02898441

Treatments Being Tested

Low Dose Computed Tomography

Eligibility Screening for a NCI Pediatric Oncology Branch Research Study

N/A

Patients who are being considered for participation in a NCI Pediatric Onco...

Status

Completed

Location

National Institutes of Health Clinical Center, 9000 Rockville Pike

Start Date

2001-09-24

Trial ID

NCT00026780

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

PHASE3

This phase III trial compares stereotactic body radiation therapy (SBRT), (...

Status

Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2023-12-14

Trial ID

NCT05946213

Treatments Being Tested

Biospecimen Collection Bone Scan Computed Tomography External Beam Radiation Therapy Magnetic Resonance Imaging Positron Emission Tomography Quality-of-Life Assessment Questionnaire Administration Stereotactic Body Radiation Therapy

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

This phase II trial tests the effectiveness and safety of artificial intell...

Status

Recruiting

Location

Northwestern University

Start Date

2023-11-20

Trial ID

NCT05802186

Treatments Being Tested

Computed Tomography Magnetic Resonance Imaging Positron Emission Tomography Quality-of-Life Assessment Radiology, Treatment Planning Stereotactic Body Radiation Therapy X-Ray Imaging

Previous Next